[Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].

Subjects

Subjects :

Biopsy
Humans
Neoplasms diagnosis
Neoplastic Cells, Circulating pathology
Predictive Value of Tests
Prognosis
Risk Factors
Tumor Burden
Cell-Free System pathology
DNA, Neoplasm genetics
Molecular Diagnostic Techniques
Neoplasms genetics
Neoplasms therapy
Neoplastic Cells, Circulating metabolism
Precision Medicine methods

Details

Language :

German

ISSN :

1432-1963

Volume :

36

Issue :

1

Database :

MEDLINE

Journal :

Der Pathologe

Publication Type :

Academic Journal

Accession number :

25533324

Full Text :

https://doi.org/10.1007/s00292-014-2069-x